64CuCl2 PET/CT in presurgical evaluation of prostate cancer in patients with high risk of extracapsular disease

Completed

• Conditions: Prostate cancer diagnosis; Cancer; Malignant neoplasm of prostate

• Registration Number: ISRCTN58371625
• Lead Sponsor: Magna Graecia University of Catanzaro (Italy)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2014-01-31
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 20

Inclusion Criteria

1. Age > 18 years
2. High-risk prostate cancer patients defined planned for surgical treatment (radical prostatectomy with lymphadenectomy)
3. Prostate-specific antigen (PSA) > 20 ng/ml
4. Biopsy gleason score 8-10
5. Stage = cT3a
6. Negative bone scintigraphy and magnetic resonance imaging (MRI) of the pelvis negative for metastatic disease

Exclusion Criteria

1. Age < 18 years
2. Evidence of metastatic disease
3. Other tumours diagnosed within the past 5 years, except basal cell or squamous cell skin carcinoma, if properly treated
4. Other medical or psychological diseases that could interfere with the participation in the study and follow-up controls
5. Refusal to participate in the study and anonymous publication of data
6. Participation in other clinical trials, including the follow-up period

Study & Design

• Study Type: Observational
• Study Design: Not specified